The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws

AAOMS, 2007, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 65, 369, 10.1016/j.joms.2006.11.003

Abu-Id, 2006, Bisphosphonate-associated osteonecrosis of the jaw, Mund Kiefer Gesichtschir, 10, 73, 10.1007/s10006-005-0670-0

Abu-Id, 2008, “Bis-phossy jaws” – high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw, J Craniomaxillofac Surg, 36, 95, 10.1016/j.jcms.2007.06.008

Badros, 2008, Natural history of osteonecrosis of the jaw in patients with multiple myeloma, J Clin Oncol, 26, 5904, 10.1200/JCO.2008.16.9300

Badros, 2006, Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors, J Clin Oncol, 24, 945, 10.1200/JCO.2005.04.2465

Bagan, 2005, Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases, J Oral Pathol Med, 34, 120, 10.1111/j.1600-0714.2004.00269.x

Bamias, 2005, Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors, J Clin Oncol, 23, 8580, 10.1200/JCO.2005.02.8670

Boonyapakorn, 2008, Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies, Oral Oncol, 44, 857, 10.1016/j.oraloncology.2007.11.012

Carlson, 2009, The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 85, 10.1016/j.joms.2009.01.006

Chuah, 2005, Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells, Leukemia, 19, 1896, 10.1038/sj.leu.2403949

Engroff, 2007, Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?, J Oral Maxillofac Surg, 65, 2374, 10.1016/j.joms.2006.07.012

Fliefel, 2015, Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review, Int J Oral Maxillofac Surg, 44, 568, 10.1016/j.ijom.2015.01.026

Greenberg, 2004, Intravenous bisphosphonates and osteonecrosis, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 98, 259, 10.1016/j.tripleo.2004.08.001

Lemound, 2012, Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap, Clin Oral Investig, 16, 1143, 10.1007/s00784-011-0596-x

Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1

Marx, 2005, Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment, J Oral Maxillofac Surg, 63, 1567, 10.1016/j.joms.2005.07.010

Migliorati, 2003, Bisphosphonates and oral cavity avascular bone necrosis, J Clin Oncol, 21, 4253, 10.1200/JCO.2003.99.132

Migliorati, 2005, Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy, Cancer, 104, 83, 10.1002/cncr.21130

Miksad, 2011, Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw, Oncologist, 16, 121, 10.1634/theoncologist.2010-0183

Miyazaki, 2012, Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel, BJU Int, 110, E520, 10.1111/j.1464-410X.2012.11205.x

Mücke, 2009, Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction, J Craniomaxillofac Surg, 37, 291, 10.1016/j.jcms.2008.12.004

Mücke, 2015, Free flap reconstruction for patients with bisphosphonate related osteonecrosis of the jaws after mandibulectomy, J Craniofac Surg

Mücke, 2015, Are infective blood measurements predictors of recurrence in patients with bisphosphonate-related osteonecrosis of the jaws?, Br J Oral Maxillofac Surg

Mücke, 2011, Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws, J Cancer Res Clin Oncol, 137, 907, 10.1007/s00432-010-0953-1

Nocini, 2009, Vascularized fibula flap reconstruction of the mandible in bisphosphonate-related osteonecrosis, Eur J Surg Oncol, 35, 373, 10.1016/j.ejso.2008.05.002

Otto, 2010, Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism, J Oral Maxillofac Surg, 68, 2837, 10.1016/j.joms.2010.07.017

Otto, 2012, Bisphosphonate-related osteonecrosis of the jaws – characteristics, risk factors, clinical features, localization and impact on oncological treatment, J Craniomaxillofac Surg, 40, 303, 10.1016/j.jcms.2011.05.003

Otto, 2015, Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development?, J Craniomaxillofac Surg, 43, 847, 10.1016/j.jcms.2015.03.039

Pautke, 2009, Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 471, 10.1016/j.joms.2008.09.037

Ruggiero, 2009, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws – 2009 update, J Oral Maxillofac Surg, 67, 2

Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004

Seth, 2010, Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws, Laryngoscope, 120, 2165, 10.1002/lary.21062

Spinelli, 2014, Microsurgical reconstruction after bisphosphonate-related osteonecrosis of the jaw: our experience with fibula free flap, J Craniofac Surg, 25, 788, 10.1097/SCS.0000000000000833

Stockmann, 2010, Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up, Support Care Cancer, 18, 449, 10.1007/s00520-009-0688-1

Thumbigere-Math, 2009, Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients, J Oral Maxillofac Surg, 67, 1904, 10.1016/j.joms.2009.04.051

Trauner, 1952, The alveolar ridge plasty on t he lower jaw on the lingual side to improve the position of the lower prosthesis, Osterr Z Stomatol, 49, 419

Vercruysse, 2014, Outcomes of osseous free flap reconstruction in stage III bisphosphonate-related osteonecrosis of the jaw: systematic review and a new case series, J Craniomaxillofac Surg, 42, 377, 10.1016/j.jcms.2014.01.005

Vescovi, 2008, Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 66, 831, 10.1016/j.joms.2007.11.025

Vescovi, 2006, Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?, J Oral Maxillofac Surg, 64, 1460, 10.1016/j.joms.2006.05.042

Vogel, 2002, Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy, Med Monatsschr Pharm, 25, 193

Voss, 2012, Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients, J Craniomaxillofac Surg, 40, 719, 10.1016/j.jcms.2012.01.005

Wang, 2003, Osteonecrosis of the jaws associated with cancer chemotherapy, J Oral Maxillofac Surg, 61, 1104, 10.1016/S0278-2391(03)00328-8

Woo, 2006, Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws, Ann Intern Med, 144, 753, 10.7326/0003-4819-144-10-200605160-00009

Wutzl, 2006, Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients, Wien Klin Wochenschr, 118, 473, 10.1007/s00508-006-0644-8

Wutzl, 2012, Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws, Head Neck, 34, 194, 10.1002/hed.21708